Title: Individualised prescriptive inference in ischaemic stroke

Abstract: The gold standard in the treatment of ischaemic stroke is set by evidence from randomised controlled trials. Yet the manifest complexities of the brain's functional, connective and vascular architectures introduce heterogeneity in treatment susceptibility that violates the premises of the underlying statistical framework, plausibly leading to substantial errors at both individual and population levels. The counterfactual nature of therapeutic inference has made quantifying the impact of this defect difficult. Employing large-scale lesion, connective, functional, genetic expression, and receptor distribution data, here we conduct a comprehensive series of semi-synthetic virtual interventional trials, quantifying the fidelity of the traditional approach in inferring individual treatment effects against biologically plausible, empirically informed ground truths. We compare the performance of machine learning models flexible enough to capture the observed heterogeneity, and find that the richness of the modelled lesion representation is decisive in determining individual-level fidelity, even where freedom from treatment allocation bias cannot be guaranteed. We are compelled to conclude that complex modelling of richly represented data is critical to individualised prescriptive inference in ischaemic stroke.